The study focuses on a small village in Columbia of 300 people, 200 of whom carry a genetic marker for Alzheimer's Disease. This is an ideal setting for a controlled, longitudinal study of the effects of a specific therapy.
According to the report. Half of the 200 suspected of being at risk of the disease will receive medication. The other half will receive a placebo. The remaining 100 who are non-carriers of the genetic marker will also receive a placebo.
The study will produce a report in the years 2020.
The race for a cure for Alzheimer's Disease is not easy, and it is not quick. This is an endurance race, not a sprint".
The Fifty Plus Racing Team is in it to win!